Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from TMO

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE:TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test.

Benzinga

Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?

Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.

Barchart

Institutions Love These 3 Companies, Should You As Well?

Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

These 3 Stocks Are Using Buybacks to Signal Market Confidence

Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?

MarketBeat

Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities

Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other performance-based payments.

Benzinga

Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Thermo Fisher Scientific Inc (NYSE:TMO) reported better-than-expected earnings for the third quarter on Wednesday.

Benzinga

Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Thermo Fisher Integrates OpenAI To Speed Drug Development

Thermo Fisher Scientific Inc. (NYSE:TMO) stock is trading higher on Thursday. The company announced plans to use artificial intelligence (AI) with OpenAI.

Benzinga

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.

Benzinga

Nathan Jibulu scores on debut as Sale kick off season with win over Gloucester

Sale 27-10 Gloucester: The hosts kickstarted the new Gallagher Prem season with a bonus-point win

The Independent UK

Women's Rugby World Cup: France forward to appeal 12-game ban for biting

Les Bleues face the Red Roses in the last four this weekend

Evening Standard

Is Thermo Fisher Scientific Stock Underperforming the Dow?

Thermo Fisher Scientific has lagged behind the Dow Jones Industrial over the past year, but analysts maintain a strong bullish outlook on its future performance.

Barchart

Thermo Fisher Positioned As Biopharma's Partner Of Choice

Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strategic acquisitions and robust growth potential. William Blair initiated coverage on Tuesday on Thermo Fisher Scientific, citing a strong…

Benzinga

This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Wall Street Bullish or Bearish on Thermo Fisher Scientific Stock?

While Thermo Fisher Scientific has underperformed the broader market over the past year, Wall Street analysts continue to hold a bullish view of the stock’s long-term prospects.

Benzinga

Why Thermo Fischer Stock Is Rising Wednesday

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, beating the street view of $5.23.

The Guardian - UK

Beware the rectangle of doom: rugby union must heed lessons of Harry Potter drama

When a toenail in touch by a defending team results in a try being chalked off for those on the attack, the game is making itself look idiotic

Barchart

Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report

Thermo Fisher Scientific is poised to release its second-quarter results later this month, and analysts project a single-digit earnings drop.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Quest Diagnostics Stock Outperforming the Nasdaq?

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

How Is Waters Corporation's Stock Performance Compared to Other Healthcare Stocks?

Even though Waters Corporation has outshined the industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

Traders Eye a Breakout in Thermo Fisher Scientific (TMO) Amid Market Undercurrents

While TMO stock has represented one of the biggest market losers, a sentiment reversal could be in the works.

Barchart

Is Thermo Fisher Scientific Stock Underperforming the Nasdaq?

Thermo Fisher Scientific has notably underperformed the Nasdaq Composite over the past year, yet analysts remain bullish about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Thermo Fisher Scientific Stock?

Although Thermo Fisher Scientific has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

The Independent UK

Newcastle boss Steve Diamond banned after directing obscenity towards match officials

The Newcastle director of rugby was hit with a six-match ban last week

The Guardian - UK

Steve Diamond’s season-ending ban was for profanity aimed at match officials

Steve Diamond’s season-ending ban came because he hit out at a group of match-day officials before telling the TMO he should retire

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.